CPHI Worldwide: PCI to Share Expertise in Serialization and Safe Handling of Potent Molecules
September 21, 2016 – Manufacturing and Packing –
Philadelphia, USA – September 21, 2016. Leading pharmaceutical provider PCI Pharma Services will bring its expertize to the stage at CPHI Worldwide (Barcelona, 4-6 October 2016) with two Speakers Corner slots at the ICSE Exhibitor Showcase.
On October 4 (13:30) David OíConnell, Director of Pharmaceutical Development, PCI Pharma Services, will present the first of the two topics – outlining the key elements for the safe handling and manufacture of solid dose potent molecules. The session will advise on the complexities of safe processing of highly potent products and key considerations when choosing an outsourcing partner including regulatory requirements.
Commenting on the theme of his presentation, David said: “The pharmaceutical landscape continues to evolve with R&D pipelines developing new chemical entities for a wide range of disease states. The market has seen a shift towards more specialist medicines such as oncological and neurological products, in turn leading to an increase in the number of potent compounds requiring expert management.
“With the complexities involved in the management of potent molecules and the regulatory requirements to ensure safe handling, it is imperative to use the right partner for successful development and manufacturing.”
The second speaker topic will be presented by Ian Parsonage, Senior Director of Global Serialization, PCI Pharma Services on 5 October (12:00) covering key considerations, lessons learned and best practices for global serialization strategy and implementation.
Ian commented: “With drug counterfeiting on the rise globally and regulatory deadlines fast approaching, the pharmaceutical supply chain will soon be at critical point to ensure patient safety. From drug manufacturers to distributors, supply chain partners need to make crucial decisions to upgrade production lines in compliance with traceability deadlines. Iím looking forward to sharing insights and best practices on how to execute a serialization strategy at the event.”
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 36,000 visiting pharma professionals over three days. Over 2,500 exhibitors from over 150 countries gather at the event to attend more than 100 free industry seminars.
PCI will be exhibiting at CPhI on stand 3B16. To arrange a meeting, please contact sales@pciservices.com
To register for CPhI Worldwide, visit: www.cphi.com/europe
About PCI
The global healthcare industry trusts PCI for the drug development solutions that increase their productsí speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle ó from Phase 1 clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patientsí lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.
Contact
Chantel Richman / Carrie Lowe at Remarkable Content
chantel.richman@remarkablegroup.co.uk / carrie.lowe@remarkablegroup.co.uk
T: +44 (0) 1962 893 853 / 913
